The estimated Net Worth of James W. Jr. Newman is at least $0 dollars as of 30 December 2021. James Newman owns over 25,000 units of Adial Pharmaceuticals, WT EXP 073123 stock worth over $0 and over the last 6 years James sold ADILW stock worth over $0.
Sign up
James Newman ADILW stock SEC Form 4 insiders trading
James has made over 3 trades of the Adial Pharmaceuticals, WT EXP 073123 stock since 2020, according to the Form 4 filled with the SEC. Most recently James bought 25,000 units of ADILW stock worth $67,250 on 30 December 2021.
The largest trade James's ever made was buying 25,000 units of Adial Pharmaceuticals, WT EXP 073123 stock on 30 December 2021 worth over $67,250. On average, James trades about 5,464 units every 64 days since 2018. As of 30 December 2021 James still owns at least 34,644 units of Adial Pharmaceuticals, WT EXP 073123 stock.
You can see the complete history of James Newman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's James Newman's mailing address?
James's mailing address filed with the SEC is 4870 SADLER ROAD, STE 300, , GLEN ALLEN,, VA, 23060.
Insiders trading at Adial Pharmaceuticals, WT EXP 073123
Over the last 6 years, insiders at Adial Pharmaceuticals, WT EXP 073123 have traded over $948,500 worth of Adial Pharmaceuticals, WT EXP 073123 stock and bought 344,044 units worth $452,385 . The most active insiders traders include Bankole A. Johnson, William B. Iii Stilley et Kevin Schuyler. On average, Adial Pharmaceuticals, WT EXP 073123 executives and independent directors trade stock every 145 days with the average trade being worth of $0. The most recent stock trade was executed by Kevin Schuyler on 29 September 2023, trading 700 units of ADILW stock currently worth $1,918.
What does Adial Pharmaceuticals, WT EXP 073123's logo look like?
Complete history of James Newman stock trades at Adial Pharmaceuticals, WT EXP 073123
Adial Pharmaceuticals, WT EXP 073123 executives and stock owners
Adial Pharmaceuticals, WT EXP 073123 executives and other stock owners filed with the SEC include:
-
James W. Jr. Newman,
Director -
Joseph Truluck,
Chief Financial Officer -
Bankole A. Johnson,
Director -
Robertson H. Gilliland,
Director -
Tony Goodman,
Chief Operating Officer -
J. Kermit Anderson,
Director -
Jack W Reich,
Director -
Kevin Schuyler,
Director -
William B. Iii Stilley,
Director -
Cary J Claiborne,
Chief Executive Officer